DNMT3A and myelodysplastic syndrome: For instance, mutations in DNMT3A and TET2 disrupt normal clonal hematopoiesis and are implicated in the transformation of HSCs into myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) 10-12.